| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/20/2002 | WO2001076576A3 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001070231A3 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries |
| 06/20/2002 | WO2001064755A3 Isoxazole gegen virale erkrankungen |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2001056590A3 Utilization of protein kinase inhibitor alpha |
| 06/20/2002 | WO2001054771A3 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 06/20/2002 | WO2001054652A8 A method of inducing autovaccination against hiv infection using structured treatment interruptions |
| 06/20/2002 | WO2001052860A3 Method and composition for modulating an immune response |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001037818A3 Medicament and combination of compatible medicaments |
| 06/20/2002 | WO2001027154A3 Membrane translocating peptide drug delivery system |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 06/20/2002 | WO2000052210A9 Methods for targeting rna molecules |
| 06/20/2002 | US20020077579 Sterile bicarbonate-free dialysis concentrate solutions |
| 06/20/2002 | US20020077366 Novel cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules |
| 06/20/2002 | US20020077360 Administering to a mammal a retinoid campound which binds specifically or selectively to a RAR alpha retinoid receptors in preference over RAR beta and RAR Gamma retinoid receptors, for therapy and prophylaxisof disease or condition |
| 06/20/2002 | US20020077349 Method of treating age-related vision impairment |
| 06/20/2002 | US20020077343 H2 receptor antagonist compounds in combination with nitric oxide donors, compostions and methods of use |
| 06/20/2002 | US20020077342 For use in therapy of epilepsy, depression, tension, gastrointestinal disorders, pain, inflammation |
| 06/20/2002 | US20020077340 Pyridone inhibitors of fatty acid binding protein and method |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077328 Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain |
| 06/20/2002 | US20020077319 Combination of GABA agonists and aldose reductase inhibitors |
| 06/20/2002 | US20020077317 For use in therapy of hyperglycemia, cancer, rheumatoid arthritis, systemic lupus erythematosus, psoriasis, scleroderma, corneal diseases, diabetic retinopathy associated with neovascularization, macular degenration, ovulation |
| 06/20/2002 | US20020077315 Useful for treating wounds |
| 06/20/2002 | US20020077314 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 06/20/2002 | US20020077301 Administering combination of farnesyl transferase inhibitor (FTI) and signal transduction inhibitor (STD in a therapeutically effective amount, wherein proliferation of cells is reduced and/ or apoptosis of cells is enhanced |
| 06/20/2002 | US20020077299 Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2 |
| 06/20/2002 | US20020077296 High-throughput screening method |
| 06/20/2002 | US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 06/20/2002 | US20020077294 Method of treating blood disorders |
| 06/20/2002 | US20020077291 Method of treatment of tumors using transforming growth factor-alpha |
| 06/20/2002 | US20020077283 Blocking interaction of caveolin with a protein in vivo by administering peptide which comprises caveolin scaffolding domain |
| 06/20/2002 | US20020077274 Administering therapeutically effective amount of a compound that inhibits cGMP-specific phosphodiesterase (PDE5) for therapy of Parkinson's disease |
| 06/20/2002 | US20020077273 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 06/20/2002 | US20020076821 Monitoring iron-complex products; obtain heme containing chemical product, subjet to a variety of spectrum analyses, compare to control |
| 06/20/2002 | US20020076810 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 06/20/2002 | US20020076796 2786, a novel human aminopeptidase |
| 06/20/2002 | US20020076795 Novel TRF1 binding protein, methods of use thereof |
| 06/20/2002 | US20020076783 Plants and plants cells expressing histidine tagged intimin |
| 06/20/2002 | US20020076777 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076750 Peptide for use as tools in human therapeutics and diagnostics |
| 06/20/2002 | US20020076702 Evaluating prostaglandin response to preferential modulators; obtain sample, incubate with modulator, compare profile with control, determine if human had prostaglandin response to moduator based on differences in control and sample profiles |
| 06/20/2002 | US20020076455 Novel preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability |
| 06/20/2002 | US20020076452 Provides synergistic anti-inflammatory effects in response to physical or chemical injury or abnormal immune stimulation; first component a sesquiterpene lactone species, diterpene lactone and a triterpene species as second component |
| 06/20/2002 | US20020076448 Anti-snoring composition |
| 06/20/2002 | US20020076423 Cosmetic or dermatological formulations for the care and cooling of the skin after sunbathing |
| 06/20/2002 | US20020076383 Administering an aerosolized mixture of lipid crystals comprised of a mixture of one or more lipids surfactants and spreading agents in powder form and propellants directly to the ear canal |
| 06/20/2002 | US20020076382 As well as drug delivery devices and dosage forms |
| 06/20/2002 | DE10063224A1 Drug formulation useful e.g. for treating angina or hypertension contains pyrazolo (4,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin |
| 06/20/2002 | DE10063223A1 Drug formulation useful e.g. for treating angina or hypertension contains thieno (2,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin, |
| 06/20/2002 | DE10063221A1 Pharmaceutical formulation containing phosphodiesterase V inhibitor, preferably benzothienopyrimidine derivative, and antithrombotic agent, useful e.g. for treating pulmonary hypertension or congestive heart failure |
| 06/20/2002 | DE10063111A1 Replikationsassay zur Auffindung antiviraler Substanzen Replication assay for the detection of antiviral substances |
| 06/20/2002 | DE10062712A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden New pharmaceutical compositions based on anticholinergics and corticosteroids |
| 06/20/2002 | DE10061876A1 Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Arylated furan and thiophenecarboxamides, processes for their preparation, their use as a medicine and pharmaceutical compositions containing them |
| 06/20/2002 | DE10061161A1 Neue humane Androgenrezeptor-Varianten New human androgen receptor variants |
| 06/20/2002 | DE10060807A1 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, ortho-substituted nitrogen-containing Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/20/2002 | CA2447900A1 Drug delivery compositions and medical devices containing block copolymer |
| 06/20/2002 | CA2432736A1 Silenced anti-cd28 antibodies and use thereof |
| 06/20/2002 | CA2431800A1 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 06/20/2002 | CA2431747A1 Treatment of male sexual dysfunction |
| 06/20/2002 | CA2431095A1 Arylated furan- and thiophenecarboxamides, with potassium channel-blocking action |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2430905A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430901A1 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | CA2430760A1 Antilipemic agents |
| 06/20/2002 | CA2430736A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430458A1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | CA2429952A1 Method for generating immortal dendritic cell lines |
| 06/20/2002 | CA2429352A1 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/20/2002 | CA2427271A1 Inflammatory markers for detection and prevention of diabetes mellitus |
| 06/20/2002 | CA2425513A1 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 06/20/2002 | CA2365517A1 Sterile bicarbonate-free dialysis concentrate solutions |
| 06/19/2002 | EP1215587A2 Adenosine monophosphate deaminase crystal structure |
| 06/19/2002 | EP1215497A1 Diagnostics for transmissible spongiform encephalopathy |
| 06/19/2002 | EP1215283A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215207A2 Salts of isoleucyl-thiazolidine and -pyrrolidine and their use as dipeptidylpeptidase inhibitors |
| 06/19/2002 | EP1214944A1 Percutaneous absorption agents |
| 06/19/2002 | EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 06/19/2002 | EP1214937A2 Terfenadine carboxylate and the treatment of dermal irritation |
| 06/19/2002 | EP1214936A2 Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214893A1 Health promoting compositions |
| 06/19/2002 | EP1214598A2 Screening for inhibitors of "paired helical filaments" |
| 06/19/2002 | EP1214593A2 Screening for compounds modulating mitochondrial proton leak |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214397A2 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway |
| 06/19/2002 | EP1214345A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 06/19/2002 | EP1214341A1 Dendritic cell membrane protein fire |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214326A1 Inhibitors of prenyl-protein transferase |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214312A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |